(Q45866741)

17 December 2017

title

PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years (English)

1 reference

17 December 2017

adenosine deaminase deficiency

main subject

1 reference

M S Hershfield

1

1 reference

17 December 2017

publication date

1 September 1995

1 reference

17 December 2017

Clinical Immunology and Immunopathology

published in

1 reference

17 December 2017

volume

76

1 reference

17 December 2017

issue

3 Pt 2

1 reference

17 December 2017

page(s)

S228-32

1 reference

17 December 2017

Treatment of adenosine deaminase deficiency with polyethylene glycol-modified adenosine deaminase

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990306-2

7 January 2021

Adenosine deaminase deficiency with late onset of recurrent infections: response to treatment with polyethylene glycol-modified adenosine deaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990306-2

7 January 2021

Insulin-dependent diabetes mellitus and severe atopic dermatitis in a child with adenosine deaminase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990306-2

7 January 2021

T lymphocyte ontogeny in adenosine deaminase-deficient severe combined immune deficiency after treatment with polyethylene glycol-modified adenosine deaminase

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990306-2

7 January 2021

Heterogeneity of phenotype in two siblings with adenosine deaminase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990306-2

7 January 2021

IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990306-2

7 January 2021

European experience of bone-marrow transplantation for severe combined immunodeficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990306-2

7 January 2021

Severe combined immunodeficiency: a retrospective single-center study of clinical presentation and outcome in 117 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990306-2

7 January 2021

Severe combined immunodeficiency of reduced severity due to homozygosity for an adenosine deaminase missense mutation (Arg253Pro).

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990306-2

7 January 2021

Novel splicing, missense, and deletion mutations in seven adenosine deaminase-deficient patients with late/delayed onset of combined immunodeficiency disease. Contribution of genotype to phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990306-2

7 January 2021

Four new adenosine deaminase mutations, altering a zinc-binding histidine, two conserved alanines, and a 5′ splice site

1 reference

https://api.crossref.org/works/10.1016%2FS0090-1229%2895%2990306-2

7 January 2021

10.1016/S0090-1229(95)90306-2

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017